South America Clinical Trials Market

ID: MRFR/MED/48509-HCR
200 Pages
Rahul Gotadki
Last Updated: April 06, 2026
South America Clinical Trials Market Research Report: Size, Share, Trend Analysis By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Observational, Expanded Access), By Therapeutic Area (Oncology, Cardiology, Neurology, Infectious Diseases, Endocrinology), By End Use (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations) and By Regional (Brazil, Mexico, Argentina, Rest of South America) - Growth Outlook & Industry Forecast 2025 To 2035
South America Clinical Trials Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)4.37%
2024 Market Size$ 2,639.2 Million
2025 Market Size$ 2,754.53 Million
2035 Market Size$ 4,223.6 Million
Key Players
Covance
IQVIA
PPD
Charles River Laboratories
Medpace
Syneos Health
Trends
  • Regulatory Improvements
  • Increased Collaboration
  • Technological Advancements
Opportunities
  • Increasing Regulatory Support
  • Growing Investment in Biotechnology
  • Rising Demand for Innovative Therapies
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Medical Device, BY Phase (USD Million)
      1. 4.1.1 Phase I
      2. 4.1.2 Phase II
      3. 4.1.3 Phase III
      4. 4.1.4 Phase IV
    2. 4.2 Medical Device, BY Study Design (USD Million)
      1. 4.2.1 Interventional
      2. 4.2.2 Observational
      3. 4.2.3 Expanded Access
    3. 4.3 Medical Device, BY Therapeutic Area (USD Million)
      1. 4.3.1 Oncology
      2. 4.3.2 Cardiology
      3. 4.3.3 Neurology
      4. 4.3.4 Infectious Diseases
      5. 4.3.5 Endocrinology
    4. 4.4 Medical Device, BY End Use (USD Million)
      1. 4.4.1 Pharmaceutical Companies
      2. 4.4.2 Biotechnology Companies
      3. 4.4.3 Contract Research Organizations
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Medical Device
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Covance (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 IQVIA (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 PPD (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Charles River Laboratories (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Medpace (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Syneos Health (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Parexel International (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Wuxi AppTec (CN)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 KCR (PL)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 SOUTH AMERICA MARKET ANALYSIS BY PHASE
    3. 6.3 SOUTH AMERICA MARKET ANALYSIS BY STUDY DESIGN
    4. 6.4 SOUTH AMERICA MARKET ANALYSIS BY THERAPEUTIC AREA
    5. 6.5 SOUTH AMERICA MARKET ANALYSIS BY END USE
    6. 6.6 KEY BUYING CRITERIA OF MEDICAL DEVICE
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF MEDICAL DEVICE
    9. 6.9 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
    11. 6.11 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
    12. 6.12 MEDICAL DEVICE, BY PHASE, 2024 (% SHARE)
    13. 6.13 MEDICAL DEVICE, BY PHASE, 2024 TO 2035 (USD Million)
    14. 6.14 MEDICAL DEVICE, BY STUDY DESIGN, 2024 (% SHARE)
    15. 6.15 MEDICAL DEVICE, BY STUDY DESIGN, 2024 TO 2035 (USD Million)
    16. 6.16 MEDICAL DEVICE, BY THERAPEUTIC AREA, 2024 (% SHARE)
    17. 6.17 MEDICAL DEVICE, BY THERAPEUTIC AREA, 2024 TO 2035 (USD Million)
    18. 6.18 MEDICAL DEVICE, BY END USE, 2024 (% SHARE)
    19. 6.19 MEDICAL DEVICE, BY END USE, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY PHASE, 2025-2035 (USD Million)
      2. 7.2.2 BY STUDY DESIGN, 2025-2035 (USD Million)
      3. 7.2.3 BY THERAPEUTIC AREA, 2025-2035 (USD Million)
      4. 7.2.4 BY END USE, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

South America South America Clinical Trials Market Segmentation

South America Clinical Trials Market By Phase (USD Million, 2025-2035)

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

South America Clinical Trials Market By Study Design (USD Million, 2025-2035)

  • Interventional
  • Observational
  • Expanded Access

South America Clinical Trials Market By Therapeutic Area (USD Million, 2025-2035)

  • Oncology
  • Cardiology
  • Neurology
  • Infectious Diseases
  • Endocrinology

South America Clinical Trials Market By End Use (USD Million, 2025-2035)

  • South America Clinical Trials Market Companies
  • Biotechnology Companies
  • Contract Research Organizations

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.